IEL and NKG2 Receptors in Celiac Disease
IEL 和 NKG2 受体在乳糜泻中的作用
基本信息
- 批准号:7485761
- 负责人:
- 金额:$ 29.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-09 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAffinityAntigensBindingBiochemicalBiological AssayCD3 AntigensCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCeliac DiseaseCellsChronicClassCytolysisDataDatabasesDietDiseaseEpithelialEpithelial CellsEpitheliumFamilyFlow CytometryFrequenciesGeneticGliadinGlutenHLA G antigenHeat shock proteinsHistocompatibility Antigens Class IHumanImmunityImmunohistochemistryIncidenceIndividualInflammationInflammatory Bowel DiseasesIntestinesLamina PropriaLeadLigandsLinkLymphocyteLymphocyte ActivationLymphocyte SubsetLymphomaMediatingModelingMolecularNatureOrgan Culture TechniquesPatientsPatternPeptide Leader SequencesPeptidesPhosphoinositide-3-Kinase, Catalytic, Gamma PolypeptidePhosphorylationPopulationPrincipal InvestigatorProductionPropertyProtein IsoformsProteinsReceptor ActivationReceptor SignalingRegulationResolutionScanningSeriesSignal PathwaySignal TransductionSpecificityStagingStressSurfaceSystemT-Cell ReceptorT-LymphocyteTechniquesTestingUrsidae FamilyWheatalpha-beta T-Cell Receptorbasecell transformationcytokinein vivointestinal epitheliumintraepithelialnovelnovel therapeuticsprogramsreceptorreceptor expression
项目摘要
DESCRIPTION (provided by applicant): Celiac disease is a common inflammatory intestinal disease induced by dietary gluten in genetically predisposed individuals. While the presence of HLA-DQ2 or DQ8-restricted gliadin-specific CD4 T cells is an essential component of the disease in the gut lamina propria, convergent observations indicate that stress of the epithelium lining the gut leads to the induction of MHC class-1 like ligands which in turn expand and activate intraepithelial lymphocytes (IEL) with cytolytic activity. Activated lELs not only contribute to the destruction of the epithelium, but they undergo transformation into lymphomas whh increased frequency. This proposal will explore at the cellular and molecular level the interactions between the diseased celiac epithelium and lELs. Specifically, studies will focus on the epithelial induction of HLA-E and MIC and their interaction with their cognate NKG2 receptors expressed by lELs. Specific aim 1 will use spectratyping and sequencing to perform high resolution analysis of the clonal composition of the IEL T cell receptor repertoire at different stages of the disease and in normal controls. Specific aim 2 will determine the regulation of expression and function of the NKG2 receptors that recognize HLA-E and MIC on celiac lELs. Specific aim 3 will further dissect the molecular and biochemical basis of NKG2 receptor signaling in celiac lELs. Specific aim 4 will study the expression of HLA-E and MIC by celiac intestinal epithelial cells and their induction by gliadin and stress in vivo and in organ culture.
Collectively, these studies will dissect the fine regulation of human effector CTLs in a diseased intestinal epithelium by a novel ligand/receptor system linking innate and adaptive immunity.
描述(由申请人提供):乳糜泻是一种常见的炎症性肠道疾病,由饮食麸质引起的遗传易感性个体。虽然HLA-DQ2或DQ8限制的麦醇溶蛋白特异性CD4 T细胞是肠道层次的疾病的重要组成部分,但收敛观察表明,肠道内衬的上皮的压力会导致MHC类1的诱导MHC类(如内部和激活的)Inspithelial lymphiptiles lymphictel lymphiptiles(Intriptial cylytip cy)。活化的LEL不仅有助于上皮的破坏,而且会转化为淋巴瘤WHH的频率增加。该建议将在细胞和分子水平探索患病的腹腔上皮和叶子之间的相互作用。具体而言,研究将集中于HLA-E和MIC的上皮诱导以及它们与LELS表达的同源NKG2受体的相互作用。具体目标1将使用频谱分型和测序对IEL T细胞受体库的克隆组成进行高分辨率分析,并在疾病的不同阶段和正常对照阶段进行。具体目标2将确定识别HLA-E和MIC在乳糜泻上的NKG2受体的表达和功能的调节。具体的目标3将进一步剖析腹腔LELS中NKG2受体信号传导的分子和生化基础。具体目标4将研究腹腔肠上皮细胞的HLA-E和MIC的表达,以及它们在体内和器官培养中的麦醇溶蛋白和应激的诱导。
总的来说,这些研究将通过与先天性和适应性免疫联系的新型配体/受体系统中的患病肠上皮中的人类效应CTL进行细致调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BANA JABRI其他文献
BANA JABRI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BANA JABRI', 18)}}的其他基金
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease
乳糜泻中致病相关转谷氨酰胺酶 2 的定位
- 批准号:
10704104 - 财政年份:2021
- 资助金额:
$ 29.34万 - 项目类别:
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease
乳糜泻中致病相关转谷氨酰胺酶 2 的定位
- 批准号:
10296119 - 财政年份:2021
- 资助金额:
$ 29.34万 - 项目类别:
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease
乳糜泻中致病相关转谷氨酰胺酶 2 的定位
- 批准号:
10483182 - 财政年份:2021
- 资助金额:
$ 29.34万 - 项目类别:
GATA4 as a window into the link between metabolism and immunity
GATA4 作为代谢与免疫之间联系的窗口
- 批准号:
8570897 - 财政年份:2013
- 资助金额:
$ 29.34万 - 项目类别:
GATA4 as a window into the link between metabolism and immunity
GATA4 作为代谢与免疫之间联系的窗口
- 批准号:
8715690 - 财政年份:2013
- 资助金额:
$ 29.34万 - 项目类别:
IEL and NKG2 Receptors in Celiac Disease
IEL 和 NKG2 受体在乳糜泻中的作用
- 批准号:
7120637 - 财政年份:2005
- 资助金额:
$ 29.34万 - 项目类别:
IEL and NKG2 Receptors in Celiac Disease
IEL 和 NKG2 受体在乳糜泻中的作用
- 批准号:
7677961 - 财政年份:2005
- 资助金额:
$ 29.34万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向KRAS新抗原TCR-T细胞的亲和力优化和抗肿瘤功能分析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向KRAS新抗原TCR-T细胞的亲和力优化和抗肿瘤功能分析
- 批准号:82202991
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于新抗原受体可变域的赭曲霉毒素A竞争物与VHH抗体互作的亲和力调控机制
- 批准号:32102067
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
免疫分析异源竞争模式中半抗原设计机制研究
- 批准号:31800776
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
T 细胞对由突变的驱动癌基因产生的克隆新抗原作出反应的分子机制。
- 批准号:
10185280 - 财政年份:2021
- 资助金额:
$ 29.34万 - 项目类别:
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
T 细胞对由突变的驱动癌基因产生的克隆新抗原作出反应的分子机制。
- 批准号:
10363712 - 财政年份:2021
- 资助金额:
$ 29.34万 - 项目类别:
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10406250 - 财政年份:2019
- 资助金额:
$ 29.34万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF ANTIBODY RESPONSES AND IMMUNITY
抗体反应和免疫的转录调控
- 批准号:
8901917 - 财政年份:2012
- 资助金额:
$ 29.34万 - 项目类别: